Aarey Drugs & Pharmaceuticals Limited (BOM:524412)
India
· Delayed Price · Currency is INR 69.20
-1.28 (-1.82%)
At close: Mar 9, 2026
BOM:524412 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 40.24 | 46.84 | 37.71 | 65.55 | 65.14 | Upgrade
|
| Depreciation & Amortization | - | 19.45 | 16.98 | 15.74 | 19.88 | 9.2 | Upgrade
|
| Other Operating Activities | - | 48.34 | 30.44 | 28.27 | 18.82 | 25.55 | Upgrade
|
| Change in Accounts Receivable | - | 509.96 | 53.02 | -534.97 | 257.29 | -658.79 | Upgrade
|
| Change in Inventory | - | -108.05 | -58.57 | -151.35 | 47.77 | -14.65 | Upgrade
|
| Change in Accounts Payable | - | -264.02 | 16.12 | 176.7 | -6.78 | 325.9 | Upgrade
|
| Change in Income Taxes | - | 0.77 | -4.58 | -8.24 | 9.43 | - | Upgrade
|
| Change in Other Net Operating Assets | - | -143.68 | -130.18 | 423.33 | -406.97 | 302.41 | Upgrade
|
| Operating Cash Flow | - | 103 | -29.94 | -12.81 | 4.99 | 54.77 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | -90.89% | 91.69% | Upgrade
|
| Capital Expenditures | - | -52.04 | -7.22 | -10.44 | -22.01 | -28.79 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0.05 | - | Upgrade
|
| Investment in Securities | - | -7.35 | -9.8 | 14.85 | -23.89 | - | Upgrade
|
| Other Investing Activities | - | - | - | - | 13.75 | - | Upgrade
|
| Investing Cash Flow | - | -59.39 | -17.02 | 4.41 | -32.1 | -28.79 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 10.21 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -12.38 | -11.36 | - | - | -0.19 | Upgrade
|
| Net Debt Issued (Repaid) | - | -12.38 | -11.36 | 10.21 | - | -0.19 | Upgrade
|
| Issuance of Common Stock | - | 16.51 | 105.14 | - | 82.32 | - | Upgrade
|
| Other Financing Activities | - | -48.95 | -37.93 | 3.33 | -59.79 | -24.32 | Upgrade
|
| Financing Cash Flow | - | -44.82 | 55.85 | 13.54 | 22.53 | -24.51 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0 | -0 | - | - | Upgrade
|
| Net Cash Flow | - | -1.21 | 8.89 | 5.14 | -4.58 | 1.47 | Upgrade
|
| Free Cash Flow | - | 50.96 | -37.16 | -23.25 | -17.03 | 25.98 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | 33.99% | Upgrade
|
| Free Cash Flow Margin | - | 1.07% | -0.92% | -0.56% | -0.34% | 0.74% | Upgrade
|
| Free Cash Flow Per Share | - | 1.80 | -1.46 | -0.91 | -0.71 | 1.11 | Upgrade
|
| Cash Interest Paid | - | 35.42 | 41.95 | 25.4 | 19.1 | 23.18 | Upgrade
|
| Cash Income Tax Paid | - | 19.09 | 13.25 | 22.79 | 35.9 | 16.64 | Upgrade
|
| Levered Free Cash Flow | - | -157.35 | -21.19 | -288.63 | 71.5 | -47.73 | Upgrade
|
| Unlevered Free Cash Flow | - | -135.21 | 5.03 | -272.75 | 82.83 | -33.24 | Upgrade
|
| Change in Working Capital | - | -5.02 | -124.19 | -94.53 | -99.27 | -45.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.